Companies / Aprea Therapeutics, Inc.

Aprea Therapeutics, Inc.

Nasdaq: APRECIK 1781983DOYLESTOWN, PA

Financials

Revenue
Net income$-12.60M
Total debt
Cash$41.23M
Diluted EPS$-1.93
Shares outstanding12.6M

Ownership

12.6M shares outstanding · as of Aug 12, 2026
3.6%Insiders
Ownership
Insiders3.58%450,787
Institutions19.51%2,456,437
Public float76.91%9,683,912

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 3

View all →
Insider% of sharesShares
Gilad OrenCEOPresident/CEO · Director
3.13%393,895
Hamill John P.SrVP/CFO/Prin Fin & Acct Ofcr
0.35%43,528
0.11%13,364

Institutional holders 24

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 30, 2026Gilad Oren
CEO
BuyCommon Stock$25.0K+28K
+8.13%
373,720
2.97% of shares
low
Jan 30, 2026Hamill John P.
Executive
BuyCommon Stock$5.1K+6K
+20.55%
33,433
0.27% of shares
low
Jun 16, 2026Henneman John B III
Director
GrantCommon Stock$0+3K
+30.65%
13,364
0.11% of shares
low
Mar 12, 2026Gilad Oren
CEO
GrantCommon Stock$0+20K
+5.40%
393,895
3.13% of shares
low
Mar 12, 2026Hamill John P.
Executive
GrantCommon Stock$0+10K
+30.19%
43,528
0.35% of shares
low
Jun 16, 2026Henneman John B III
Director
GrantStock Options (Right to Buy)+13K
12,555
0.10% of shares
low
Mar 12, 2026Gilad Oren
CEO
GrantStock Options (Right to Buy)+81K
80,700
0.64% of shares
low
Mar 12, 2026Hamill John P.
Executive
GrantStock Options (Right to Buy)+40K
40,380
0.32% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Orin HirschmanPassive13G/A
Nantahala Capital Management, LLCPassive13G/A
Orin HirschmanPassive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
APRECommon StockEquity03836J201BBG00Q6Q3K37
APRE03836J102